Synopsys (NASDAQ:SNPS)‘s stock had its “buy” rating reiterated by equities research analysts at Royal Bank of Canada in a research report issued to clients and investors on Friday.
Other research analysts also recently issued reports about the stock. Zacks Investment Research downgraded shares of Synopsys from a “hold” rating to a “strong sell” rating in a report on Monday, December 4th. Needham & Company LLC upped their price target on shares of Synopsys from $83.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, November 30th. BidaskClub upgraded shares of Synopsys from a “hold” rating to a “buy” rating in a report on Tuesday, January 23rd. KeyCorp reiterated an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a report on Thursday. Finally, DA Davidson reiterated a “buy” rating and set a $105.00 price target (up from $91.00) on shares of Synopsys in a report on Tuesday, November 28th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $97.33.
Synopsys (NASDAQ SNPS) opened at $85.24 on Friday. Synopsys has a 1 year low of $69.42 and a 1 year high of $94.80. The company has a market cap of $12,705.44, a P/E ratio of 315.70, a price-to-earnings-growth ratio of 3.76 and a beta of 1.04. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.04 and a current ratio of 0.68.
Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, February 21st. The semiconductor company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.00 by $0.10. Synopsys had a net margin of 1.63% and a return on equity of 6.72%. The business had revenue of $769.40 million during the quarter, compared to the consensus estimate of $750.43 million. During the same period in the previous year, the business earned $0.94 earnings per share. The company’s revenue was up 17.9% on a year-over-year basis. equities research analysts anticipate that Synopsys will post 2.24 EPS for the current year.
In related news, Director Chrysostomos L. Nikias sold 21,074 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $89.78, for a total value of $1,892,023.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Chi-Foon Chan sold 3,750 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $89.78, for a total value of $336,675.00. The disclosure for this sale can be found here. Insiders have sold 65,442 shares of company stock valued at $5,779,693 over the last quarter. Company insiders own 1.82% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Cerebellum GP LLC acquired a new stake in Synopsys in the fourth quarter valued at $124,000. Robecosam AG increased its holdings in Synopsys by 69.2% in the fourth quarter. Robecosam AG now owns 2,200 shares of the semiconductor company’s stock valued at $188,000 after purchasing an additional 900 shares during the period. IBM Retirement Fund acquired a new stake in Synopsys in the fourth quarter valued at $201,000. Conning Inc. acquired a new stake in Synopsys in the fourth quarter valued at $205,000. Finally, Checchi Capital Advisers LLC acquired a new stake in Synopsys in the fourth quarter valued at $205,000. Institutional investors and hedge funds own 88.58% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Synopsys (SNPS) Earns “Buy” Rating from Royal Bank of Canada” was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2018/02/24/synopsys-snps-earns-buy-rating-from-royal-bank-of-canada.html.
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.